Biodiversity and medicines
Nagoya Protocol and its Implications on Pharmaceutical Industry
IP Guidelines and Agreements for Access and Use of Genetic and Natural Resources A presentation By D.CALAB GABRIEL of K&S Partners 06 th April 2010.
Training Manual on Risk Assessment of Living Modified Organisms in the context of the Cartagena Protocol on Biosafety (aligned with the Roadmap for Risk.
Treaty governance
Biodiversity & conservation sai
Indian acts governing different IPRs
What is the value of biodiversity
Biodiversity cites seminar
Karade D,Sivaramakrishnan S, Venkateswaran K, Reddy R.S. (May 2012) Characterization of Genetic Variability among Cowpea (Vigna Unguiculata L. Walp) germplasm using Morphological,
Westmacott Et Al 200 Managment of Damaged Coral Reefs
Protecting endangered plant and animal species